Biofilm Formation by Cryptococcus neoformans

Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MB-0006-2014.

Abstract

The fungus Cryptococcus neoformans possesses a polysaccharide capsule and can form biofilms on medical devices. The increasing use of ventriculoperitoneal shunts to manage intracranial hypertension associated with cryptococcal meningoencephalitis highlights the importance of investigating the biofilm-forming properties of this organism. Like other microbe-forming biofilms, C. neoformans biofilms are resistant to antimicrobial agents and host defense mechanisms, causing significant morbidity and mortality. This chapter discusses the recent advances in the understanding of cryptococcal biofilms, including the role of its polysaccharide capsule in adherence, gene expression, and quorum sensing in biofilm formation. We describe novel strategies for the prevention or eradication of cryptococcal colonization of medical prosthetic devices. Finally, we provide fresh thoughts on the diverse but interesting directions of research in this field that may result in new insights into C. neoformans biology.

MeSH terms

  • Antifungal Agents / therapeutic use
  • Biofilms / drug effects*
  • Biofilms / growth & development
  • Cell Adhesion / physiology
  • Cryptococcosis / prevention & control*
  • Cryptococcus neoformans / drug effects*
  • Drug Resistance, Multiple, Fungal
  • Equipment Contamination / prevention & control*
  • Fungal Capsules / metabolism*
  • Fungal Polysaccharides / metabolism*
  • Humans
  • Meningitis, Cryptococcal / drug therapy
  • Meningitis, Cryptococcal / pathology
  • Prostheses and Implants / microbiology*
  • Quorum Sensing / physiology
  • Ventriculoperitoneal Shunt

Substances

  • Antifungal Agents
  • Fungal Polysaccharides